Association study using single nucleotide polymorphisms in the estrogen receptor β (ESR2) gene for preeclampsia

Hypertension Research

Volumn 27, Issue 12, 2004, Pages 903-909

  Maruyama, Aya ^a   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Mizutani, Yoshihiro ^a   Furuya, Kiyohide ^a   Yamamoto, Tatsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Estrogen receptor; Genetic; Polymorphism; Preeclampsia; Single nucleotide polymorphism

Indexed keywords

ESTROGEN RECEPTOR BETA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DATA BASE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PREECLAMPSIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR BETA; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY;

EID: 15844367462     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.903     Document Type: Article

References (25)

1. Roberts JM, Cooper DW: Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-56.
2. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T: Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997; 34: 525-526.
3. Yamada N, Arinami T, Yamakawa-Kobayashi K, et al: The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Gnet 2000; 45: 138-141.
4. Gurdol F, Isbilen E, Yilmaz H, Isbir T, Dirican A: The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Clin Chim Acta 2004; 34: 127-131.
5. Malina AN, Laivuori HM, Agatisa PK, et al: The Trp64Arg polymorphism of the beta3-adrenergic receptor is not increased in women with preeclampsia. Am J Obstet Gynecol 2004; 190: 779-783.
6. Malamitsi-Puchner A, Tziotis J, Evangelopoulos D, et al Gene analysis of the N-terminal region of the estrogen receptor alpha in preeclampsia. Steroids 2001; 66: 695-700.
7. Miya Y, Sumino, H, Ichikawa S, et al: Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women. Hypertens Res 2002; 25: 153-159.
8. Minami N, Mori N, Nagasaka M, Kurosawa H, Kanazawa M, Kohzuki M: Effect of estrogen on pressor responses to alpha1-adrenoreceptor agonist in conscious female rats. Hypertens Res 2002; 25: 609-613.
9. Sumino H, Ichikawa S, Ohyama Y, et al: Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. Hypertens Res 2003; 26 53-58.
10. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895.
11. Walter P, Green S, Greene G, et al: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 1985; 82 7889-7893.
12. Kuiper GG, Carlsson B, Grandien K, et al: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863-870.
13. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925-5930.
14. Mendelsohn ME: Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002; 89 (Suppl 12): 12E-17E; discussion 17E-18E.
15. Mishell DR Jr, Mendelsohn ME: Introduction: the role of hormone replacement therapy in prevention and treatment of cardiovascular disease in postmenopausal women. Am J Cardiol 2002; 89 (Suppl 12): 1E-4E.
16. Pare G, Krust A, Karas RH, et al: Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 2002; 90: 1087-1092.
17. Karas RH, Schulten H, Pare G, et al: Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 2001; 89: 534-539.
18. Zhu Y, Bian Z, Lu P, et al: Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505-508.
19. Nakayama T, Soma M, Rahmutula D, Ozawa Y, Kanmatsuse K: Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit 2001; 7: 345-349.
20. Nakayama T, Soma M, Mizutani Y, et al: A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. Hypertens Res 2002; 25: 395-401.
21. Nakayama T, Soma M, Haketa A, et al: Haplotype analysis of the prostacyclin synthase gene and essential hypertension. Hypertens Res 2003; 26: 553-557.
22. Sharkey LC, McCune SA, Yuan O, Lange C, Fray J: Spontaneous pregnancy-induced hypertension and intrauterine growth restriction in rats. Am J Hypertens 2001; 14: 1058-1066.
23. Forest JC, Masse J, Moutquin JM, Radouco-Thomas M: Essential hypertension: physiopathology and prospects for early detection. Clin Biochem 1989; 22: 483-489.
24. Qiu C, Williams MA, Leisenring WM, et al: Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003; 41: 408-413.
25. Ness RB, Markovic N, Bass D, Harger G, Roberts JM: Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003; 102: 1366-1371.